The US Food and Drug Administration has designated a recall from Medtronic as class I, its most serious type.
The company initiated the recall of nearly 350,000 implantable defibrillators in May because the devices may deliver a reduced energy...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?